YieldMax MRNA Option Income Strategy ETF

$19.43-1.42 %$MRNY

About YieldMax MRNA Option Income Strategy ETF (MRNY)

YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund established on October 23, 2023 and traded on the NYSE exchange. The fund manages approximately $0.10 billion in net assets, making it a significant ETF in its category.

With an expense ratio of 1.00%, YieldMax MRNA Option Income Strategy ETF is considered a competitive investment option for investors seeking exposure to this asset class.

The fund currently offers a dividend yield of 2.32%, providing income-seeking investors with moderate distributions alongside potential capital appreciation.

What You Need to Know About MRNY

  • Inception Date: October 23, 2023 - providing 2 years of track record
  • Assets Under Management: $0.10 billion in net assets
  • Expense Ratio: 1.00% annually
  • Dividend Yield: 2.32% annual yield
  • Exchange: NYSE
  • Type: Traditional ETF

Compare MRNY with other investment options: ETF Screener | Stock Screener

Price History

-5.90%

Fund Details

Dividend Yield2.32%
Inception Date2023-10-23
Net Assets$99.9M
Net Expense Ratio0.01%